Published in N Engl J Med on March 18, 1976
Hereditary sensory and autonomic neuropathies: types II, III, and IV. Orphanet J Rare Dis (2007) 1.59
Pacemakers in patients with familial dysautonomia--a review of experience with 20 patients. Clin Auton Res (2005) 1.54
Pindolol acts as beta-adrenoceptor agonist in orthostatic hypotension: therapeutic implications. Br Med J (Clin Res Ed) (1981) 1.51
A world without pain or tears. Clin Auton Res (2006) 0.94
Familial sinus node dysfunction with autosomal dominant inheritance. Br Heart J (1978) 0.92
Cardiac sympathetic hypo-innervation in familial dysautonomia. Clin Auton Res (2008) 0.87
Dermal microdialysis provides evidence for hypersensitivity to noradrenaline in patients with familial dysautonomia. J Neurol Neurosurg Psychiatry (2002) 0.86
Catecholamines 101. Clin Auton Res (2010) 0.84
Catecholamine measurements in clinical medicine. Postgrad Med J (1983) 0.81
Highly abnormal thermotests in familial dysautonomia suggest increased cardiac autonomic risk. J Neurol Neurosurg Psychiatry (1998) 0.81
Renal transplantation in familial dysautonomia: report of two cases and review of the literature. Clin J Am Soc Nephrol (2010) 0.80
Assessing microcirculation in familial dysautonomia by laser Doppler flowmeter. Clin Auton Res (1998) 0.80
Plasma catechols in familial dysautonomia: a long-term follow-up study. Neurochem Res (2008) 0.79
Effect of age and combined sprint and strength training on plasma catecholamine responses to a Wingate-test. Eur J Appl Physiol (2014) 0.78
Cardiac pacing in patients with familial dysautonomia--there is nothing simple about sudden death. Clin Auton Res (2005) 0.77
Documented transient third-degree atrioventricular block and asystole in a child with familial dysautonomia. Pediatr Cardiol (2007) 0.77
A primate model of parkinsonism: selective destruction of dopaminergic neurons in the pars compacta of the substantia nigra by N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine. Proc Natl Acad Sci U S A (1983) 3.39
Sympathetic cardioneuropathy in dysautonomias. N Engl J Med (1997) 3.14
Simultaneous liquid-chromatographic determination of 3,4-dihydroxyphenylglycol, catecholamines, and 3,4-dihydroxyphenylalanine in plasma, and their responses to inhibition of monoamine oxidase. Clin Chem (1986) 2.95
Chronic Parkinsonism secondary to intravenous injection of meperidine analogues. Psychiatry Res (1979) 2.61
The sympathetic-nervous-system defect in primary orthostatic hypotension. N Engl J Med (1977) 2.28
Plasma atrial natriuretic peptide is unstable under most storage conditions. Circulation (1992) 2.24
Selective release of newly synthesized norepinephrine from the cat spleen during sympathetic nerve stimulation. J Pharmacol Exp Ther (1968) 1.99
Metabolism of normetanephrine-H3 in rat brain--identification of conjugated 3-methoxy-4-hydrophenylglycol as the major metabolite. Biochem Pharmacol (1968) 1.86
Cardiac sympathetic nerve function in congestive heart failure. Circulation (1996) 1.84
Dopamine biosynthesis is selectively abolished in substantia nigra/ventral tegmental area but not in hypothalamic neurons in mice with targeted disruption of the Nurr1 gene. Mol Cell Neurosci (1998) 1.75
Proportional release of norepinephrine and dopamine- -hydroxylase from sympathetic nerves. Science (1971) 1.68
3-methoxy-4-hydroxyphenylglycol sulfate in brain and cerebrospinal fluid. Biochem Pharmacol (1968) 1.64
Hormonal responses to graded surgical stress. Arch Intern Med (1987) 1.59
Pharmacologic distinction of different orthostatic hypotension syndromes. Neurology (1981) 1.59
Biochemical aspects of release of norepinephrine and other amines from sympathetic nerve endings. Pharmacol Rev (1966) 1.58
Biochemical changes during clomipramine treatment of childhood obsessive-compulsive disorder. Arch Gen Psychiatry (1987) 1.56
Plasma noradrenaline increases with age. Nature (1976) 1.56
Validity and reliability of liquid chromatography with electrochemical detection for measuring plasma levels of norepinephrine and epinephrine in man. Life Sci (1981) 1.55
The effects of psychoactive drugs on norepinephrine-3-H metabolism in brain. Biochem Pharmacol (1967) 1.54
Catecholamine metabolism: basic aspects and clinical significance. Pharmacol Rev (1985) 1.53
A more sensitive and specific radioenzymatic assay for catecholamines. Life Sci (1990) 1.50
False adrenergic transmitters. Annu Rev Pharmacol (1968) 1.50
The effect of fetal mesencephalon implants on primate MPTP-induced parkinsonism. Histochemical and behavioral studies. J Neurosurg (1990) 1.48
Disulfiram-induced fulminating hepatitis: guidelines for liver-panel monitoring. J Clin Psychiatry (1988) 1.48
Accelerated risk of hypertensive blood pressure recordings among Alzheimer caregivers. J Psychosom Res (1999) 1.47
L-Dopa-induced release of cerebral monoamines. Science (1970) 1.47
Determination of metanephrines in plasma by liquid chromatography with electrochemical detection. Clin Chem (1993) 1.47
Cardiac epinephrine synthesis. Regulation by a glucocorticoid. Circulation (1991) 1.46
The effect of drugs on the release of norepinephrine-H from central nervous system tissued by electrical stimulation in vitro. J Pharmacol Exp Ther (1967) 1.44
Gender differences in autonomic cardiovascular regulation: spectral, hormonal, and hemodynamic indexes. J Appl Physiol (1985) (2001) 1.43
Natural history of left ventricular function during 1 year after acute myocardial infarction: comparison with clinical, electrocardiographic and biochemical determinations. Am J Cardiol (1980) 1.42
Plasma dihydroxyphenylglycol and the intraneuronal disposition of norepinephrine in humans. J Clin Invest (1988) 1.41
The rate of norepinephrine synthesis measured in vivo during short intervals; influence of adrenergic nerve impulse activity. J Pharmacol Exp Ther (1968) 1.40
2-Amino-3-(methylamino)-propanoic acid (BMAA) in cycad flour: an unlikely cause of amyotrophic lateral sclerosis and parkinsonism-dementia of Guam. Neurology (1990) 1.40
Relationship between plasma norepinephrine and sympathetic neural activity. Hypertension (1983) 1.40
Production of a specific antiserum to rat brain glutamic acid decarboxylase by injection of an antigen-antibody complex. Neuroscience (1981) 1.40
Biosynthesis of N-acetyl dopamine by the American cockroach. J Insect Physiol (1967) 1.39
Hemiparkinsonism in monkeys after unilateral internal carotid artery infusion of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP). Life Sci (1986) 1.39
The analgesic effects of R(+)-WIN 55,212-2 mesylate, a high affinity cannabinoid agonist, in a rat model of neuropathic pain. Neurosci Lett (1997) 1.39
Galactorrhea-amenorrhea: psychological interaction with neuroendocrine function. Am J Obstet Gynecol (1976) 1.37
Medication errors with inhalant epinephrine mimicking an epidemic of neonatal sepsis. N Engl J Med (1984) 1.37
Enhanced release of dopamine- -hydroxylase from sympathetic nerves by calcium and phenoxybenzamine and its reversal by prostaglandins. Proc Natl Acad Sci U S A (1971) 1.37
Inhibition of release of dopamine- -hydroxylase and norepinephrine from sympathetic nerves by colchicine, vinblastine, or cytochalasin-B (hypogastric nerve stimulation-exocytosis-microtubules-microfilaments-guinea pig). Proc Natl Acad Sci U S A (1972) 1.36
Metabolism of tyramine-3H and octopamine-3H by rat brain. Biochem Pharmacol (1969) 1.35
Use of plasma norepinephrine for evaluation of sympathetic neuronal function in man. Life Sci (1976) 1.33
Circulating catecholamines and sympathetic activity after head injury. Neurosurgery (1981) 1.32
Heterogeneous neurochemical responses to different stressors: a test of Selye's doctrine of nonspecificity. Am J Physiol (1998) 1.30
Catechols in post-mortem brain of patients with Parkinson disease. Eur J Neurol (2010) 1.30
Inhibition of dopamine-beta-hydroxylase by disulfiram in vivo. J Pharmacol Exp Ther (1966) 1.29
Increased sympathetic nervous system activity in alcoholic patients treated with disulfiram. Am J Psychiatry (1977) 1.28
Elevation of adrenal tyrosine hydroxylase and phenylethanolamine-N-methyl transferase by repeated immobilization of rats. Endocrinology (1970) 1.27
Enhanced release of dopamine -hydroxylase and norepinephrine from sympathetic nerves by dibutyryl cyclic adenosine 3', 5'-monophosphate and theophylline. Mol Pharmacol (1973) 1.27
Stimulus-induced release of substances from olfactory bulb using the push-pull cannula. Nature (1968) 1.26
Interleukin-6 and tumor necrosis factor-alpha production after acute psychological stress, exercise, and infused isoproterenol: differential effects and pathways. Psychosom Med (2000) 1.24
Effect of handling and forced immobilization on rat plasma levels of epinephrine, norepinephrine, and dopamine-beta-hydroxylase. Endocrinology (1978) 1.24
Mechanism of cardiovascular actions of the chromogranin A fragment catestatin in vivo. Peptides (1998) 1.24
Age-adjusted plasma norepinephrine levels are similar in normotensive and hypertensive subjects. N Engl J Med (1977) 1.24
Sympathoadrenal system in stress. Interaction with the hypothalamic-pituitary-adrenocortical system. Ann N Y Acad Sci (1995) 1.23
On the mechanism of release of norepinephrine from sympathetic nerves induced by depolarizing agents and sympathomimetic drugs. Mol Pharmacol (1975) 1.23
High plasma norepinephrine levels in patients with major affective disorder. Am J Psychiatry (1982) 1.21
Letter: Sympathoadrenal medullary activity in young, spontaneously hypertensive rats. Nature (1975) 1.21
CNS stimulants and the look-alike drugs. Psychiatr Clin North Am (1984) 1.21
Plasma levels of norepinephrine. Ann Intern Med (1978) 1.20
Relationship of arousals from sleep to sympathetic nervous system activity and BP in obstructive sleep apnea. Chest (1999) 1.19
Mechanism of release of norepinephrine from peripheral adrenergic neurones by the calcium ionophores X 537A and A 23187. Life Sci (1974) 1.19
Prevalence and recognition of depression among primary care outpatients. J Fam Pract (1987) 1.19
A sensitive radioimmunoassay for 7S nerve growth factor antigens in serum and tissues. J Neurochem (1971) 1.19
Chromogranin A in human hypertension. Influence of heredity. Hypertension (1995) 1.18
Metabolic stress in PC12 cells induces the formation of the endogenous dopaminergic neurotoxin, 3,4-dihydroxyphenylacetaldehyde. J Neurosci Res (2000) 1.16
Increased norepinephrine levels and decreased dopamine-beta-hydroxylase activity in primary autism. Arch Gen Psychiatry (1977) 1.15
Acceleration of norepinephrine synthesis in the rat submaxillary gland in vivo during sympathetic nerve stimulation. Life Sci (1967) 1.15
Factors influencing blood pressure in salt-sensitive patients with hypertension. Am J Med (1980) 1.14
Stress-induced norepinephrine release in the hypothalamic paraventricular nucleus and pituitary-adrenocortical and sympathoadrenal activity: in vivo microdialysis studies. Front Neuroendocrinol (1995) 1.14
The role of nerve growth factor in the ramification of sympathetic nerve fibres into the rat iris in organ culture. J Neurochem (1972) 1.13
Renal denervation in the rat: analysis of glomerular and proximal tubular function. Am J Physiol (1983) 1.13
Endogenous glucocorticoids restrain catecholamine synthesis and release at rest and during immobilization stress in rats. Endocrinology (1993) 1.13
A model of fulminant hepatic failure in the rabbit. Gastroenterology (1978) 1.12
Heredity and the autonomic nervous system in human hypertension. Curr Hypertens Rep (2000) 1.12
Postoperative ileus in the rat: physiopathology, etiology and treatment. Ann Surg (1973) 1.11
Plasma catecholamine concentrations in unanesthetized rats during sleep, wakefulness, immobilization and after decapitation. J Pharmacol Exp Ther (1977) 1.10
Specific genetic deficiencies of the A and B isoenzymes of monoamine oxidase are characterized by distinct neurochemical and clinical phenotypes. J Clin Invest (1996) 1.09
Local dental anesthesia with epinephrine. Minimal effects on the sympathetic nervous system or on hemodynamic variables. Arch Intern Med (1983) 1.09
Electrical field-stimulated release of norepinephrine-H3 from rat atrium: effects of ions and drugs. J Pharmacol Exp Ther (1969) 1.09
Marihuana: studies on the disposition and metabolism of delta-9-tetrahydrocannabinol in man. Science (1970) 1.08
Segregation and linkage studies of plasma dopamine-beta-hydroxylase (DBH), erythrocyte catechol-O-methyltransferase (COMT), and platelet monoamine oxidase (MAO): possible linkage between the ABO locus and a gene controlling DBH activity. Am J Hum Genet (1982) 1.08
Norepinephrine metabolism in hypertrophied rat hearts. Nature (1965) 1.07
Catecholamine storage vesicle protein expression in genetic hypertension. Blood Press (1999) 1.07